Header Logo

Connection

JIANMING XU to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications JIANMING XU has written about Clinical Trials as Topic.
JIANMING XU
Connection Strength
0.018
Clinical Trials as Topic
  1. A SNP in steroid receptor coactivator-1 disrupts a GSK3? phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol. 2012 Feb; 26(2):220-7.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.